Physician

Robert Lavon Weeks, M.D.

According to 2025 Medicare claims, Robert Weeks, M.D. (NPI: 1487653168) practices family practice in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP OF GEORGIA LLC (NPI: 1013313857; TIN: 202265068) and primary practice location at 31406-3928. Weeks is affiliated with the Privia Quality Network of Georgia (ACO ID: A3236), participating under the MSSP model.

Weeks' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 880 traditional Medicare patients, billed 32,129 HCPCS/CPT codes, and received $350,126 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 16,543 prescription claims across 816 beneficiaries totaling $1,978,048 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 104 claims. Open Payments data shows 44 records totaling $780. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $809,999 to $1,978,048. In contrast, DME billing represents a smaller volume and rose steadily, from $12,080 to $16,059.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	434	41,763	$205,685
2016	984	41,518	$355,950
2017	945	39,495	$349,703
2018	956	46,791	$388,600
2019	936	45,182	$362,742
2020	833	45,366	$336,946
2021	1,057	39,376	$333,460
2022	834	35,190	$402,701
2023	960	33,900	$381,709
2024	880	32,129	$350,126

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	546	16,245	$809,999
2016	543	15,418	$737,514
2017	619	16,976	$890,055
2018	607	17,208	$1,060,918
2019	660	16,280	$1,042,526
2020	686	15,436	$1,083,483
2021	758	15,259	$1,286,293
2022	827	17,439	$1,642,521
2023	839	17,809	$2,129,334
2024	816	16,543	$1,978,048

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	57	240	$7,372
2016	73	242	$5,407
2017	22	190	$6,347
2018	38	291	$10,020
2019	41	170	$3,462
2020	42	232	$12,115
2021	22	225	$9,469
2022	14	172	$18,018
2023	14	132	$17,751
2024	12	104	$13,876

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	243	504	$71
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	518	2,806	$58
80061	Blood test, lipids (cholesterol and triglycerides)	228	431	$13
36415	Insertion of needle into vein for collection of blood sample	234	474	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	235	440	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	306	18,226	$333,021
Ozempic	Semaglutide	272	10,402	$330,338
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	253	9,300	$196,160
Mounjaro	Tirzepatide	134	3,822	$138,523
Trulicity	Dulaglutide	95	3,852	$131,237

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$10,227
A5054	Ostomy pouch, closed; for use on barrier with flange (2 piece), each	N	N/R	13	$1,556
A4414	Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each	N	N/R	12	$1,368
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	40	$618
A5120	Skin barrier, wipes or swabs, each	N	N/R	12	$84

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$780	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert Lavon Weeks, M.D.?

Tedicare shows public-source Medicare data for Robert Lavon Weeks, M.D. (NPI 1487653168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Lavon Weeks, M.D. have ACO affiliation data?

Robert Lavon Weeks, M.D. is shown with ACO affiliation data for Privia Quality Network of Georgia (MSSP, ACO ID A3236).

What billing organization is linked to Robert Lavon Weeks, M.D.?

Robert Lavon Weeks, M.D. is linked to PRIVIA MEDICAL GROUP OF GEORGIA LLC (billing NPI 1013313857) in the available physician profile data.

Does Robert Lavon Weeks, M.D. have Open Payments data?

Robert Lavon Weeks, M.D. has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.